← All companies
CGTX
Cognition Therapeutics, Inc.
$0.89
-0.02 -2.67%
Key statistics
from XBRL data in SEC filingsMarket cap
$79.8M
Revenue (TTM)
—
Net income (TTM)
-$19.6M
EPS (TTM)
$-0.23
P/E ratio
—
Dividend yield
—
Free cash flow
-$24.6M
Cash
$31.1M
Total assets
$36.1M
Gross margin
—
52-week range
$0.55 – $3.83
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 24, 2026
8-K
Shareholder vote results
Jun 18, 2026
8-K
Regulation FD disclosure
Jun 4, 2026
8-K
Other events
May 21, 2026
10-Q
Quarter ended 2026-03-31
May 8, 2026
8-K
Results of operations (earnings release)
May 7, 2026
10-K
Fiscal year ended 2025-12-31
Mar 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 26, 2026
8-K
Other events
Mar 2, 2026
8-K
Other events
Jan 27, 2026
8-K
Entered a material agreement; Terminated a material agreement
Dec 18, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Other events
Sep 15, 2025
8-K
Entered a material agreement
Aug 28, 2025
8-K
Other events
Aug 26, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Shareholder vote results
Jun 20, 2025
8-K
Other events
Jun 3, 2025
8-K
Other events
Jun 2, 2025
8-K
Other events
May 8, 2025
10-Q
Quarter ended 2025-03-31
May 7, 2025
8-K
Results of operations (earnings release)
May 7, 2025
10-K
Fiscal year ended 2024-12-31
Mar 20, 2025
8-K
Results of operations (earnings release)
Mar 20, 2025
8-K
Other events
Mar 12, 2025
8-K
Other events
Feb 26, 2025
8-K
Other events
Jan 28, 2025
8-K
Regulation FD disclosure
Jan 13, 2025
8-K
Other events
Dec 18, 2024
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Results of operations (earnings release)
Nov 13, 2024
8-K
Regulation FD disclosure
Oct 1, 2024
8-K
Delisting notice or listing-rule failure
Sep 13, 2024
8-K
Regulation FD disclosure
Aug 28, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Other events
Jul 29, 2024
8-K
Shareholder vote results
Jun 7, 2024